Sunday, March 26, 2017

Targeted Delivery of Our UCB Derived hMSCs

Liver-targeting Delivery via Intravenous Injection of Cells

Check out how our UCB Human Mesenchymal Stem Cells are engineered for delivery to the liver: Hahn, Sei Kwang (Pohang-si, KR), Kim, Yun Seop (Seoul, KR), Kong, Won Ho (Pohang-si, KR),Kim, Hyemin (Daegu, KR). HYALURONIC ACID DERIVATIVES AND COMPOSITION FOR CELL-SURFACE ENGINEERING USING THE SAME. United States Patent Application 20170067012.
Images: Neuromics' hMSCS in culture
Preparation method of a hyaluronic acid derivative capable of modifying the surface of cells and also having biocompatibility, biodegradability, and liver-targeting deliver property, and use of the hyaluronic acid derivative prepared thereby as a liver-targeting cell delivery system.

No comments: